Rxsight Statements
RX
Data from Rxsight`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
30 Jun, 2024
Next reporting period:
28 Sep, 2024
Report frequency:
Quarterly
Earnings release date:
07 Nov, 2024
Expected release date:
07 Nov, 2024
Rxsight Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
34.887
18.2 %
100
10.637
30.5
24.25
17.2 %
69.5
8.268
23.7
24.307
69.7
32.583
3.9 %
93.4
-8.333
21.9 %
-23.9
2.27
6.5
—
0
-6.063
33.3 %
-17.4
0.016
0.05
-6.079
33.2 %
-17.4
-0.158
38.456
29.512
3.3 %
100
8.827
29.9
20.685
17.2 %
70.1
7.989
27.1
23.342
79.1
31.355
10 %
106.2
-10.67
1.7 %
-36.2
1.579
5.4
—
0
-9.091
1.1 %
-30.8
0.009
0.03
-9.1
0.8 %
-30.8
-0.247
36.843
28.58
28.7 %
100
10.926
38.2
17.654
28.6 %
61.8
7.292
25.5
21.181
74.1
28.506
8.6 %
99.7
-10.852
13.3 %
-38
1.657
5.8
—
0
-9.195
25.8 %
-32.2
-0.018
-0.06
-9.177
26.1 %
-32.1
-0.255
35.978
22.2
6.7 %
100
8.47
38.2
13.73
14.2 %
61.8
7.05
31.8
19.15
86.3
26.24
2.3 %
118.2
-12.51
8.2 %
-56.4
1.52
6.8
—
0
-12.4
10 %
-55.9
0.01
0.05
-12.42
10 %
-55.9
-0.35
35.66
20.81
19 %
100
8.8
42.3
12.02
15.9 %
57.8
7.35
35.3
18.25
87.7
25.64
9.2 %
123.2
-13.63
-4 %
-65.5
0.21
1
—
0
-13.78
-4.3 %
-66.2
0.03
0.1
-13.8
-4.5 %
-66.3
-0.4
34.5
17.49
8.7 %
100
7.12
40.7
10.37
39.8 %
59.3
7.14
40.8
16.28
93.1
23.47
4.7 %
134.2
-13.1
12.6 %
-74.9
-0.12
-0.7
—
0
-13.21
15.4 %
-75.5
—
0
-13.21
15.4 %
-75.5
-0.42
31.64
16.09
27.5 %
100
8.67
53.9
7.42
38.4 %
46.1
6.6
41
15.8
98.2
22.41
5.2 %
139.3
-14.99
6.1 %
-93.2
-0.62
-3.9
—
0
-15.61
7.2 %
-97.02
0.01
0.06
-15.61
7.2 %
-97.02
-0.51
30.42
12.62
11.1 %
100
7.26
57.5
5.36
11.9 %
42.5
6.28
49.8
15
118.9
21.31
3.5 %
168.9
-15.96
-1.1 %
-126.5
-0.86
-6.8
—
0
-16.82
-0.5 %
-133.3
—
0
-16.82
-0.5 %
-133.3
-0.61
27.67
11.36
27.1 %
100
6.57
57.8
4.79
27.4 %
42.2
6.08
53.5
14.47
127.4
20.58
1.2 %
181.2
-15.79
4.8 %
-139
-0.94
-8.3
—
0
-16.73
4.9 %
-147.3
—
0
-16.73
4.9 %
-147.3
-0.61
27.56
8.94
6 %
100
5.18
57.9
3.76
31 %
42.1
6.63
74.2
13.69
153.1
20.34
16 %
227.5
-16.58
-13.1 %
-185.5
-1.01
-11.3
—
0
-17.59
-11.8 %
-196.8
—
0
-17.6
-11.9 %
-196.9
-0.64
27.43
8.43
45.6 %
100
5.56
66
2.87
114.2 %
34
5.84
69.3
11.69
138.7
17.53
21.3 %
207.9
-14.66
-11.8 %
-173.9
-1.07
-12.7
—
0
-15.73
-24.1 %
-186.6
—
0
-15.73
-24.2 %
-186.6
-0.57
27.49
5.79
18.2 %
100
4.45
76.9
1.34
265.4 %
23.1
5.31
91.7
9.14
157.9
14.45
10.6 %
249.6
-13.11
5.5 %
-226.4
-1.07
-18.5
1.5
25.9
-12.68
5.9 %
-219
—
0
-12.67
6 %
-218.8
-0.46
27.32
4.9
40.8 %
100
5.71
116.5
-0.81
-172.3 %
-16.5
6.56
133.9
6.5
132.7
13.06
6.6 %
266.5
-13.88
-24.6 %
-283.3
-0.81
-16.5
1.21
24.7
-13.47
-98.1 %
-274.9
—
0
-13.48
-97.9 %
-275.1
-0.51
26.29
3.48
-29.1 %
100
2.37
68.1
1.12
-18.8 %
32.2
6.64
190.8
5.6
160.9
12.25
26.5 %
352
-11.14
-34.4 %
-320.1
-0.68
-19.5
5.02
144.3
-6.8
-125.9 %
-195.4
0.01
0.3
-6.81
-137.3 %
-195.7
-0.26
26.29
4.91
69.9 %
100
3.53
71.9
1.38
1625 %
28.1
5.27
107.3
4.4
89.6
9.68
2.1 %
197.1
-8.29
11.8 %
-168.8
-0.48
-9.8
35.08
714.5
26.3
259.4 %
535.6
—
0
18.26
188 %
371.9
0.69
26.29
2.89
—
100
2.81
97.2
0.08
—
2.8
5.74
198.6
3.69
127.7
9.48
—
328
-9.4
—
-325.3
0.31
10.7
-7.41
-256.4
-16.5
—
-570.9
0.01
0.3
-20.75
—
-718
-0.79
26.29